Fenofibrate

🧮 Dose calculator

Hyperlipidemia / heterozygous familial hypercholesterolemia · Regimen source: FDA Fenofibrate · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Fenofibrate · 8.1

  “Risk Summary Limited available data with fenofibrate use in pregnant women are insufficient to determine a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingContraindicated

  Label: contraindicated while breastfeeding. FDA Fenofibrate · 4

  “… arnings and Precautions (5.2) ] . patients with preexisting gallbladder disease [see Warnings and Precautions (5.5) ] . nursing mothers [see Use in Specific Populations (8.2) ] . patients with known hypersensitivity to fenofibrate or fenofibric acid [see Warnings and Precautions (5.9) ] .”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Fenofibrate · 8.4

  “Safety and effectiveness have not been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Fenofibrate · 8.5

  “Since elderly patients have a higher incidence of renal impairment, dose selection for the elderly should be made on the basis of renal function [see Dosage and Administration (2.5) and Clinical Pharmacology (12.3) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.